Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00191022Phase 2Completed
Phase 2, randomised, double-blind trial of tradipitant in Social Anxiety Disorder (SAD) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Liebowitz Social Anxiety Scale Total Score at 12 weeks. Started Dec 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00191022.